TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
PGEN

Precigen Inc

Healthcare · Biotechnology

7.80$ +0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Precigen Inc (PGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 170 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PGEN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
191 151 135 73 83 145 129 102 171 157 139 170
93 69 50 24 35 102 85 63 130 115 102 134
10 7.6 17 9.3 25 30 6.1 14 14 30 7.5 16
74 63 45 20 29 98 80 60 121 98 56 38
14 1.6 1.2 1.0 0.7 1.2 1.1 0.6 1.1 4.4 27 72
– 0.0 0.0 – – 0.0 – – 3.1 9.6 15 20
37 27 27 25 25 19 19 15 15 15 15 15
40 41 39 5.1 4.8 4.5 4.1 3.8 3.5 3.2 2.9 2.5
43 33 38 30 28 107 143 139 129 136 118 127
33 23 29 23 21 22 24 23 32 37 21 29
1.2 1.2 1.3 1.3 1.0 1.0 0.9 0.9 1.1 1.1 1.1 1.1
2.4 1.7 4.7 4.8 4.3 3.5 3.1 3.9 6.3 12 2.6 5.3
– – – – – – – – 93 93 94 94
148 118 97 43 55 39 -14 -37 42 21 20 44
-1,931 -1,964 -1,988 -2,047 -2,071 -2,091 -2,145 -2,172 -2,318 -2,341 -2,349 -2,329
249 249 249 252 276 293 294 296 296 313 313 414

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?